Host DNA Methylation for Endometrial Cancer Screening
- Conditions
- DNA MethylationCohort StudyLiquid BiopsyCancer ScreeningEndometrial CancerCervical Cytology
- Registration Number
- NCT05290415
- Lead Sponsor
- Lei Li
- Brief Summary
Based on the previous study of NCT04651738, we performed this trial to further confirm the accuracy of host DNA CDO1 and CELF4 methylation for endometrial cancer screening in a multi-center cohort. Thirteen hospitals, including Peking Union Medical College Hospital, would enroll eligible patients in this study. The cervical cytology of 3 ml will be collected for the detection of DNA CDO1 and CELF4 methylation, and the results will compared with the endometrial histological pathology, which is achieved after collection of cervical cytology, by surgeries including hysteroscopy, dilation and curettage, total hysterectomy and others. The methylation testing would be double-blinded in operators and analysts. The study will enroll at least 10,000 patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 10000
- With uterine and uterine cervix intact
- Aged 18 years or older
- With accessible histological results of endometrium
- Signed an approved informed consents
- With accessible cervical cytology before harvesting endometrial histology
- Not meeting all of the inclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity of methylation testing One week Sensitivity of methylation testing of cervical cytology compared with histology
Specificity of methylation testing One week Specificity of methylation testing of cervical cytology compared with histology
- Secondary Outcome Measures
Name Time Method Positive predictive value of methylation testing One week Positive predictive value of methylation testing of cervical cytology compared with histology
Negative predictive value of methylation testing One week Negative predictive value of methylation testing of cervical cytology compared with histology
Trial Locations
- Locations (1)
Lei Li
🇨🇳Beijing, Beijing, China